New Alzheimer's drug enters critical test to slow memory loss

NCT ID NCT06079190

Ongoing Disease control Sponsor: GlaxoSmithKline Source: ClinicalTrials.gov ↗

Summary

This study is testing whether an investigational intravenous drug called GSK4527226 can slow the progression of early Alzheimer's disease. It will involve 367 people with mild cognitive impairment or mild dementia due to Alzheimer's, who will receive either one of two doses of the drug or a placebo over 76 weeks. The main goal is to see if the drug is safe and better than a placebo at slowing the decline in memory and daily function.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

GSK Investigational Site

San Diego, California, 92103, United States
GSK Investigational Site

Lake Mary, Florida, 32720, United States
GSK Investigational Site

Lake Worth, Florida, 33462, United States
GSK Investigational Site

Maitland, Florida, 32752, United States
GSK Investigational Site

Miami, Florida, 33176, United States
GSK Investigational Site

Orlando, Florida, 32803, United States
GSK Investigational Site

Orlando, Florida, 32804, United States
GSK Investigational Site

Stuart, Florida, 34997, United States
GSK Investigational Site

The Villages, Florida, 32159, United States
GSK Investigational Site

The Villages, Florida, 32162, United States
GSK Investigational Site

Decatur, Georgia, 30030, United States
GSK Investigational Site

Elk Grove Village, Illinois, 60007, United States
GSK Investigational Site

Chesterfield, Missouri, 63005, United States
GSK Investigational Site

Toms River, New Jersey, 08755, United States
GSK Investigational Site

Staten Island, New York, 10314, United States
GSK Investigational Site

Matthews, North Carolina, 28105, United States
GSK Investigational Site

North Canton, Ohio, 44720, United States
GSK Investigational Site

Oklahoma City, Oklahoma, 73112, United States
GSK Investigational Site

Portland, Oregon, 07210, United States
GSK Investigational Site

Houston, Texas, 77030, United States
GSK Investigational Site

Fairfax, Virginia, 22031, United States
GSK Investigational Site

Buenos Aires, C1425AGC, Argentina
GSK Investigational Site

Buenos Aires, C1428AQK, Argentina
GSK Investigational Site

Ciudad Autonoma de Buenos Aire, C1431FWO, Argentina
GSK Investigational Site

Ciudad Autonoma de Bueno, C1056ABJ, Argentina
GSK Investigational Site

Camperdown, New South Wales, 2050, Australia
GSK Investigational Site

Darlinghurst, New South Wales, 2010, Australia
GSK Investigational Site

Kogarah, New South Wales, 2217, Australia
GSK Investigational Site

Macquarie Park, New South Wales, 2113, Australia
GSK Investigational Site

Gold Coast, Queensland, 4222, Australia
GSK Investigational Site

Heidelberg, Victoria, 3079, Australia
GSK Investigational Site

Nedlands, Western Australia, 6009, Australia
GSK Investigational Site

Melbourne, Australia
GSK Investigational Site

Ottawa, Ontario, K1Z 1G3, Canada
GSK Investigational Site

Peterborough, Ontario, K9H 2P4, Canada
GSK Investigational Site

Toronto, Ontario, M3B 2S7, Canada
GSK Investigational Site

Greenfield Park, Quebec, J4V 2J2, Canada
GSK Investigational Site

Sherbrooke, Quebec, J1J 2G2, Canada
GSK Investigational Site

Helsinki, 00180, Finland
GSK Investigational Site

Kuopio, 70210, Finland
GSK Investigational Site

Oulu, 90100, Finland
GSK Investigational Site

Turku, 20520, Finland
GSK Investigational Site

Bron, 69500, France
GSK Investigational Site

Lille, 59037, France
GSK Investigational Site

Nice, 06100, France
GSK Investigational Site

Paris, 75010, France
GSK Investigational Site

Paris, 75013, France
GSK Investigational Site

Saint-Herblain, 44093, France
GSK Investigational Site

Strasbourg, 67000, France
GSK Investigational Site

Toulouse, 31300, France
GSK Investigational Site

Villeurbanne, 69100, France
GSK Investigational Site

Cologne, 50935, Germany
GSK Investigational Site

Erbach im Odenwald, 64711, Germany
GSK Investigational Site

München, 80336, Germany
GSK Investigational Site

Münster, 48149, Germany
GSK Investigational Site

Brescia, 25123, Italy
GSK Investigational Site

CefalU PA, 90015, Italy
GSK Investigational Site

Genova, 16132, Italy
GSK Investigational Site

Milan, 20132, Italy
GSK Investigational Site

Milan, 20133, Italy
GSK Investigational Site

Modena, 41126, Italy
GSK Investigational Site

Monza, 20900, Italy
GSK Investigational Site

Pavia, 27100, Italy
GSK Investigational Site

Perugia, 06129, Italy
GSK Investigational Site

's-Hertogenbosch, 5223 LA, Netherlands
GSK Investigational Site

Amsterdam, 1081 GN, Netherlands
GSK Investigational Site

Zwolle, 8025 AZ, Netherlands
GSK Investigational Site

Bergen, 5009, Norway
GSK Investigational Site

Oslo, 0450, Norway
GSK Investigational Site

Stavanger, Norway
GSK Investigational Site

Junggu, 400711, South Korea
GSK Investigational Site

Seoul, 04763, South Korea
GSK Investigational Site

Seoul, 138-736, South Korea
GSK Investigational Site

Barcelona, 08028, Spain
GSK Investigational Site

Getxo - Vizcaya, 48993, Spain
GSK Investigational Site

Madrid, 28034, Spain
GSK Investigational Site

Madrid, 28041, Spain
GSK Investigational Site

Madrid, 28046, Spain
GSK Investigational Site

Madrid, 28223, Spain
GSK Investigational Site

Pamplona, 31008, Spain
GSK Investigational Site

Salamanca, 37007, Spain
GSK Investigational Site

Terrassa - Barcelona, 08221, Spain
GSK Investigational Site

Valencia, 46026, Spain
GSK Investigational Site

Gothenburg, 431 41, Sweden
GSK Investigational Site

Malmo, 21146, Sweden
GSK Investigational Site

Stockholm, Sweden
GSK Investigational Site

Kaohsiung City, 833, Taiwan
GSK Investigational Site

Tainan, 704, Taiwan
GSK Investigational Site

Tau-Yuan, 333, Taiwan
GSK Investigational Site

Ankara, 06230, Turkey (Türkiye)
GSK Investigational Site

CapaIstanbul, 34093, Turkey (Türkiye)
GSK Investigational Site

Birmingham, B16 8LT, United Kingdom
GSK Investigational Site

Bristol, BS32 4SY, United Kingdom
GSK Investigational Site

Glasgow, ML1 4UF, United Kingdom
GSK Investigational Site

London, EC2Y 8EA, United Kingdom
GSK Investigational Site

London, W1G 8TA, United Kingdom
GSK Investigational Site

London, WC1N 3BG, United Kingdom

Conditions

Explore the condition pages connected to this study.

ALZHEIMER'S DISEASE